Lixa
PrivateLast Round
VC Round
Jun 5, 2025
Total Funding Raised
$1.53M
Company Overview
Lixa is a biotechnology company that develops small-molecule resistance modulators designed to dismantle bacterial biofilms and restore the effectiveness of existing antimicrobial treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lixa Comps
Public and private peers based on sector, stage, and business model.
Lixa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 5, 2025 | ||||
| Grant | Aug 16, 2024 | ||||
| Seed | Sep 1, 2022 |
Key People
Founding team and executive leadership
Lixa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Industries and Innovation Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 26, 2025
Grew 23% QoQ, from 13 to 16 employees.
- Sep 1, 2022
$2M round led by Ceri Org AU.
Lixa Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lixa's valuation, stock price, and market status.